Skip to content

PAR-25-288 ED diversion R34 eligibility Guide

Updated 6 official sources

Quick Answer: PAR-25-288 is an active NIMH R34 for pilot testing patient-navigation emergency department diversion models for non-urgent mental health problems.

Full answer and how we checked it

It requires a clinical trial, caps direct costs at $225,000 per year and $450,000 over 3 years, lists February 16, 2027 as the next new-application date (November 16, 2026 for resubmissions), and points larger studies to companion R01 PAR-25-289. The 2026 decision turns on 7 checks.

Who this is for: Child and adolescent mental health researchers, emergency department teams, health services researchers, community mental health partners, patient-navigation model teams, and sponsored-research offices deciding whether a pilot clinical trial fits.

Data note: This guide uses NIH PAR-25-288, companion R01 PAR-25-289, Grants.gov listing 357386, and Grantsights award-data signals first checked on June 2, 2026; NIH due dates were rechecked on October 10, 2026.

In this guide

PAR-25-288 is not a general emergency department access grant. NIH frames it around patient-navigation models for non-urgent mental health concerns, especially models that triage acuity, support caregivers, connect families to services, address barriers, and test how, why, and for whom the model works.

R34 pilot clinical trial, companion R01 fully powered study, and nonresponsive local program evaluation.

Use this guide with the live Mental Health ED Diversion R34 program record. Then compare NIH grants complete guide, NIH R01 R21 R03 K awards comparison, what is a NOFO, Healthcare Grants Complete Guide, and the Grantsights grant database.

October 2026 Source Check

According to NIH in PAR-25-288 (opens in a new tab), this R34 remains active. The June 16, July 16 and October 16, 2026 dates have passed; the next are November 16, 2026 for resubmissions and February 16, 2027 for new applications, then March 16, 2027 for resubmissions. Applications are due by 5 p.m. local time, and the notice expires January 8, 2028. NIH lists the clinical-trial status as required and the budget limit as $225,000 in direct costs per year, with $450,000 total direct costs over the project period.

According to NIH in PAR-25-289 (opens in a new tab), the companion R01 is for projects with pilot data and a fully powered effectiveness test. That source confirms the route split: PAR-25-288 for pilot testing and mechanism learning, PAR-25-289 for a larger trial.

October 10 checkCurrent source readApplicant action
StatusActive through January 8, 2028Use the live NIH table, not a copied deadline
Next new dateFebruary 16, 2027Decide now whether June 16, 2027 is more realistic
Resubmission dateNovember 16, 2026Check the prior summary statement before routing
Trial statusRequiredBuild the human-subjects and trial record early
Route splitR34 pilot versus R01 powered testStop if the study is already an R01

The date math matters here. The October 16, 2026 new-application date has passed, so the next one is February 16, 2027, then June 16, 2027, with resubmissions due November 16, 2026 and March 16, 2027. A team that hasn't yet drafted its clinical-trial record, human-subjects plan, and data safety monitoring plan may find the June date more realistic. The $450,000 cap on total direct costs over the three-year project period should shape the pilot's size before the first draft starts, and the companion R01, PAR-25-289, is the better home for a team that already has pilot data and wants to run a fully powered effectiveness test.

The $225,000 yearly direct-cost cap also forces a lean staffing plan. A budget that has to cover navigator salaries, emergency department partner time, and trial monitoring should be sketched against that cap before the team commits to a design.

Get grant deadline alerts by email

About once a week, we email a short list of open grant calls with real deadlines from different funders. It isn't limited to the programs in this guide.

No spam. Unsubscribe anytime.

7 PAR-25-288 Eligibility Stop Checks

Within 21 days, use this section as the checkpoint for the ED diversion R34 before a team builds the clinical-trial packet.

7 stop checks decide whether this route fits.

Stop checkStrong R34 signalRed flag
ModelPatient-navigation ED diversion model is centralUsual care quality-improvement project
PopulationNon-urgent mental health concernsAcute emergency treatment study
Trial statusNIH-defined clinical trial is proposedNo trial design
Pilot stageSignal detection or component testingFully powered effectiveness study
MechanismHow, why, and for whom will be testedDescriptive evaluation only
PartnershipResearch-practice partnership is specifiedSite partner is vague
Next routeR01 path is plausibleNo next effectiveness question

This R34 is strongest when the model can be piloted in a real care setting without pretending to be a full effectiveness trial.

5 Source Facts Applicants Should Know

Within 21 days, use this section as the checkpoint for the ED diversion R34 before a team builds the clinical-trial packet.

5 facts should be visible before a user scrolls.

FactSource-backed read
Funding numberPAR-25-288
MechanismR34 Planning Grant
Clinical trial statusRequired
BudgetUp to $225,000 direct costs per year and $450,000 total
ExpirationJanuary 8, 2028

NIH says the companion R01 is PAR-25-289 for larger-scale, fully powered studies. According to USAspending.gov (opens in a new tab) data, assistance listing 93.242 had about $1.77B in FY2024 obligations across 6,220 awards active that year.

What NIH Doesn't Tell You

Within 21 days, use this section as the checkpoint for the ED diversion R34 before a team builds the clinical-trial packet.

4 practical issues decide whether the R34 should move forward.

First, the model has to be a navigator model, not a general referral workflow. The intervention should include acuity triage, caregiver support, connection to mental health services, resource linkage, and help with barriers.

Second, this is a clinical trial required route. If the team is not ready to build a trial record, outcome measures, human-subjects plan, and data safety monitoring, it is not ready.

Third, the study should detect a signal, not prove final effectiveness. NIH says projects need not be statistically powered in pilot work but should detect signals of effectiveness.

Fourth, mechanism testing matters. Applications that do not evaluate mechanisms of action and their impact on primary outcomes are nonresponsive. A pilot that only reports feasibility numbers, such as how many families the navigator reached, won't answer the mechanism question NIH asks.

6 Evidence Assets That Make This R34 Stronger

Within 21 days, use this section as the checkpoint for the ED diversion R34 before a team builds the clinical-trial packet.

6 evidence assets make the application stronger. The first is a navigator model map: who delivers it, where, what training is required, what supervision exists, and what the navigator does.

The second is a setting-capacity statement. ED workflow, pediatric mental health access, caregiver needs, and community service capacity should be described plainly.

The third is a trial design memo. It should explain whether the design is randomized, adaptive, factorial, or another pilot design and why it fits the question.

The fourth is a mechanism table. Include engagement, knowledge, barriers, caregiver support, service use, symptoms, ED reuse, and family-level outcomes.

The fifth is a resource table. NIH cares whether the model can be adopted outside research settings. Training time, staff role, delivery burden, supervision, and technology needs should be visible.

The sixth is an R01 bridge. The pilot should explain what signal would justify a fully powered companion-route study.

5 Route Choices Before Drafting

Within 21 days, use this section as the checkpoint for the ED diversion R34 before a team builds the clinical-trial packet.

5 routes should be compared.

RouteBetter first read when...Why
PAR-25-288 R34Pilot testing and mechanism learning are neededRoute matches pilot stage
PAR-25-289 R01Study is fully poweredCompanion R01 is built for that
Parent clinical trial routeNavigator ED diversion is not centralTopic may fit elsewhere
Implementation studyModel is already proven and adoption is the questionR34 may be too early
Local evaluationNo research mechanism question existsNot a good NIH fit

6 Bad-Fit Signals

Within 21 days, use this section as the checkpoint for the ED diversion R34 before a team builds the clinical-trial packet.

6 bad-fit signals should be clear. First, the project does not test a navigator model. Second, the project is a traditional therapeutic or preventive intervention rather than ED diversion navigation.

Third, it is a descriptive evaluation. Fourth, it lacks mechanism testing. Fifth, it is fully powered and belongs in the R01. Sixth, the team cannot describe the practice partnership.

Those stop checks make the page more useful than a title scraper.

21-Day R34 Routing Plan

Within 21 days, use this section as the checkpoint for the ED diversion R34 before a team builds the clinical-trial packet.

Days 1 through 3 should confirm source status, due date, clinical-trial required status, budget, and companion R01 comparison.

Days 4 through 7 should map the navigator model: staff, training, supervision, site workflow, caregiver touchpoints, service links, and resource needs.

Days 8 through 12 should define the pilot trial design and endpoints. State what signal is enough for an R01.

Days 13 through 16 should build the mechanism table. Identify how the model is expected to change engagement, knowledge, barriers, service use, and outcomes.

Days 17 through 21 should prepare the practice-partnership memo and the clinical-trial packet.

7 Above-the-Fold Claims That Need Proof

Within 21 days, a team should be able to answer 7 questions: what the route funds, whether the source is open or expired, whether clinical trials are allowed, what budget rule applies, who is eligible in practice, what does not fit, and what route should be compared next.

According to NIH in the NOFO (opens in a new tab), this source should be treated as the authority for rules.

7 Route Checks Added June 2, 2026

Checked on June 2, 2026 against PAR-25-288 (opens in a new tab), the Grants.gov listing (opens in a new tab), USASpending.gov (opens in a new tab), PAR-25-289 (opens in a new tab), and Grants.gov (opens in a new tab).

CheckWhat to confirm
EligibilityConfirm the applicant, institution, and route rules for PAR-25-288 ED diversion R34 eligibility.
Source statusVerify the official listing, notices, due date, and expiration status.
BudgetCheck award size, cost limits, match, or budget logic when the source provides it.
EvidenceName the data, preliminary work, partner role, or implementation proof needed.
Bad fitStop if the project belongs in a nearby NIH or federal route.
Review criteriaTie the first page to significance, approach, team, environment, and source-specific criteria.
Next actionDecide whether to draft, ask a program contact, or redirect.

Final public checklist

  • Confirm whether R34 is the right route or whether a nearby program fits better.
  • Check budget, partner, match, or data-readiness constraints.

Sources

Next steps

Where to go next

These next pages help you move from research into a specific grant choice.

Frequently Asked Questions

What does PAR-25-288 fund?

It funds R34 pilot testing of patient-navigation emergency department diversion models for non-urgent mental health problems.

Are clinical trials required?

Yes. PAR-25-288 only accepts applications that propose clinical trials.

What budget applies?

NIH says R34 budgets are limited to $225,000 in direct costs per year and $450,000 over the three-year project period.

What is the next 2026 deadline?

The June 16, July 16 and October 16, 2026 dates have passed. NIH lists November 16, 2026 for resubmissions, then February 16, 2027 for new applications and March 16, 2027 for resubmissions. The notice expires January 8, 2028.

Who should skip this route?

Skip it if the project evaluates local practice, lacks mechanism testing, or is a fully powered effectiveness study better suited to the companion R01.

Last updated October 24, 2026. Corrected October 24, 2026: what changed. Published by Grantsights from public sources. See our editorial policy, how we build and check guides, corrections and how we make money.